IVD Acquisition Corporation Successfully Completes Acquisition of Immucor

Immucor, Inc. BLUD and TPG Capital, L.P. today announced the successful acquisition of the Company by IVD Acquisition Corporation, an affiliate of TPG Capital, for $27.00 per share in cash, or approximately $1.939 billion in the aggregate. Today, following the consummation of the tender offer and IVD Acquisition Corporation's exercise of the "top-up" option, IVD Acquisition Corporation was merged with and into the Company with the Company surviving the merger, in accordance with the merger agreement. In the merger, each share, other than shares held by IVD Holdings Inc., IVD Acquisition Corporation or the Company or shares held by the Company's shareholders who validly exercise dissenters' rights under Georgia law, not previously purchased in the tender offer was converted into the right to receive $27.00, net to the seller in cash. As a result of the completion of the merger, the Company's common stock will cease to be traded on The NASDAQ Global Select Market.